European rating of drug harms.

نویسندگان

  • Jan van Amsterdam
  • David Nutt
  • Lawrence Phillips
  • Wim van den Brink
چکیده

BACKGROUND The present paper describes the results of a rating study performed by a group of European Union (EU) drug experts using the multi-criteria decision analysis model for evaluating drug harms. METHODS Forty drug experts from throughout the EU scored 20 drugs on 16 harm criteria. The expert group also assessed criteria weights that would apply, on average, across the EU. Weighted averages of the scores provided a single, overall weighted harm score (range: 0-100) for each drug. RESULTS Alcohol, heroin and crack emerged as the most harmful drugs (overall weighted harm score 72, 55 and 50, respectively). The remaining drugs had an overall weighted harm score of 38 or less, making them much less harmful than alcohol. The overall weighted harm scores of the EU experts correlated well with those previously given by the UK panel. CONCLUSION The outcome of this study shows that the previous national rankings based on the relative harms of different drugs are endorsed throughout the EU. The results indicates that EU and national drug policy measures should focus on drugs with the highest overall harm, including alcohol and tobacco, whereas drugs such as cannabis and ecstasy should be given lower priority including a lower legal classification.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.

BACKGROUND The European Medicines Agency makes clinical study reports publicly available and publishes reasons for not approving applications for marketing authorization. Duloxetine has been approved in Europe for the treatment of stress urinary incontinence in women. The reported adverse effects of duloxetine include mental health problems and suicidality. We obtained clinical study reports fr...

متن کامل

Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review.

BACKGROUND Cancer prevention and screening guidelines are ideally suited to the task of providing high-quality benefit-harm information that informs clinical practice. We systematically examined how US guidelines present benefits and harms for recommended cancer prevention and screening interventions. METHODS We included cancer screening and prevention recommendations from: 1) the United Stat...

متن کامل

Preferences for cancer treatments: an overview of methods and applications in oncology.

This review provides cancer clinicians and researchers with an overview of methods for assessing preferences, with examples and recommendations for their application in oncology. Decisions about cancer treatments involve trade-offs between their relative benefits and harms. An individual's preference for a cancer treatment reflects their evaluation of the relative benefits and harms in comparis...

متن کامل

Quality of center day care and attunement between parents and caregivers: center day care in cross-national perspective.

In a sample of 43 Dutch infants and toddlers (mean age = 1.7 years), the quality of care at day-care centers was assessed and compared with similar quality ratings in other European and North American countries. It was hypothesized that formal characteristics of care settings and caregivers as well as attunement between caregivers and parents would be associated with quality of care. Quality of...

متن کامل

Chapter 1 Harm reduction and the mainstream

Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. We envisage harm reduction as a ‘combination intervention’, made up of a package of interventions tailored to local setting and need, which give primary emphasis to reducing the harms of drug use. We note the enhanced ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of psychopharmacology

دوره 29 6  شماره 

صفحات  -

تاریخ انتشار 2015